ADARx Pharmaceuticals, Inc.

ADARx Pharmaceuticals, Inc. financial statements

ADARx Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 3.45MEODHD
Net income−USD 73.09MEODHD
Cash and equivalentsUSD 66.52MEODHD
Total debtUSD 7.74MEODHD

ADARx Pharmaceuticals, Inc. financials on 6ix · ADARx Pharmaceuticals, Inc. on 6ix